DHA Plus a Blood Pressure Drug May Help Protect the Heart in Kidney Disease (Animal Study)
This laboratory study looked at how a gut-derived toxin called indole-3-acetic acid (IAA), which builds up in chronic kidney disease, affects the heart in rats. Researchers tested whether a DHA-enriched diet, alone or combined with the blood pressure medication captopril, could reduce heart damage caused by this toxin.
Rats with kidney disease that were exposed to IAA and treated with DHA showed faster clearance of the toxin and lower toxin levels in the blood. The combination of DHA and captopril produced the strongest protective effects, reducing markers of heart muscle damage (troponin-I, CK-MB, LDH) and helping preserve natural antioxidant defenses (SOD, catalase).
At the gene level, the combined treatment lowered activity of markers linked to heart enlargement and scarring (fibrosis), and tissue examination confirmed less structural damage to the heart muscle. The researchers also found that the treatment reduced activation of an inflammatory signaling pathway (AhR-NF-κB) and lowered levels of the inflammatory protein TNF-α.
What this means for you
This is early-stage animal research, not a human study, so it doesn’t tell us whether DHA supplements would have the same heart-protective effects in people with kidney disease. It does add to a growing body of evidence suggesting DHA may support antioxidant balance and reduce inflammatory and fibrotic processes tied to toxin buildup, which is worth watching as research develops.
Ready to start? The ALP Protocol delivers the EPA & DHA doses used in the research.
Start the ALP ProtocolSource
Molecular nutrition & food research · 2026-09-01 · DOI: 10.1002/mnfr.70593
Read the original source ↗This summary is for educational purposes only and is not medical advice. Always talk to your healthcare provider before making changes to your supplement routine.